
Novan secures USD50m private financing
Novan Therapeutics has secured USD50 million in an oversubscribed private financing led by new investor Malin Corporation with strong participation from Novan’s existing private investors throughout the Research Triangle area of North Carolina. The round closed 27 March, 2015 at USD50 million, including an August 2014 initial filing of USD10.3


